IMPACT Medicom
We are a medical communications company with a passion for developing high-quality content. We write & design content for healthcare professionals and patients in a variety of therapeutic areas. If you like our podcast, please take the time to rate it and subscribe. See our website for more information, video capsules, and podcasts at: https://www.impactmedicom.com.
IMPACT Medicom
Chronic Lymphocytic Leukemia (CLL): How do we Manage Patients During COVID-19?
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
In this episode we discuss the management of CLL patients during the COVID-19 pandemic.
Included is a discussion of:
- The initial treatment of patients with CLL during COVID-19
- The use of BTK inhibitors vs FCR
- The use of intravenous or subcutaneous immunoglobulin
- Existing guidelines for the treatment of CLL during COVID-19
- The virtual management of CLL patients
Our guest:
Dr. Pavic is a Medical Oncologist and Chief of the Hemato-Oncology department at the Centre intégré universitaire de santé et de services sociaux de l’Estrie – Centre Hospitalier Universitaire de Sherbrooke and an assistant professor in the Faculty of Medicine and Health Sciences at the Université de Sherbrooke.
Guidelines
- ASH recommendations: https://www.hematology.org/covid-19/covid-19-and-cll
- Canadian recommendations: Management of chronic lymphocytic leukemia in Canada during the coronavirus pandemic: L.H. Sehn, P. Kuruvilla, A. Christofides, J. Stakiw https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339858/pdf/conc-27-e332.pdf
**If you enjoy our podcast, please take the time to rate our podcast and subscribe**
For more great podcasts and other features, visit our website at: www.impactmedicom.com.